Quality of life, fatigue and local response of patients with unstable spinal bone metastases under radiation therapy--a prospective trial

Harald Rief, Maximiliane Heinhold, Thomas Bruckner, Ingmar Schlampp, Robert Förster, Thomas Welzel, Tilman Bostel, Jürgen Debus, Stefan Rieken, German Bone Research Group, Harald Rief, Maximiliane Heinhold, Thomas Bruckner, Ingmar Schlampp, Robert Förster, Thomas Welzel, Tilman Bostel, Jürgen Debus, Stefan Rieken, German Bone Research Group

Abstract

Background: To evaluate the local response according to stability after radiotherapy (RT) with a special focus on quality-of-life (QoL), fatigue, pain and emotional distress in patients with unstable spinal bone metastases.

Methods: In this prospective trial, 30 patients were treated from September 2011 until March 2013. The stability of osteolytic metastases in the thoracic and lumbar spine was evaluated on the basis of the Taneichi-score after three and six months. EORTC QLQ-BM22, EORTC QLQ-FA13, and QSC-R10 were assessed at baseline, and three months after RT.

Results: After 3 months, 25% (n = 6) and after 6 months 33.3% (n = 8) were classified as stable. QoL, fatigue, and emotional distress showed no difference over the course. The pain response 3 months after RT showed a significant difference (p < 0.001). Pathological fractures occurred in 8.3% of the patients (n = 2) within six months following RT.

Conclusions: Our trial demonstrated that RT can improve stability in one third of patients over a 6-months period with unstable spinal metastases. Importantly, for these patients pain relief was detected but RT had no impact on QoL, fatigue, and emotional distress.

Trial registration: Clinical trial identifier NCT01409720.

Figures

Figure 1
Figure 1
Taneichi score.
Figure 2
Figure 2
A. Overall survival, B. Bone survival. The numbers of patients at risk are mentioned above the time in months.

References

    1. Coleman RE. Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27:165–176. doi: 10.1053/ctrv.2000.0210.
    1. Wyne CM, Hu SS, Lotz JC. Biomechanically derived guidline equations for burst fracture risk prediction in the metastatically involved spine. J Spin Disord Tech. 2003;16(2):180–185. doi: 10.1097/00024720-200304000-00010.
    1. Gerszten PC, Welch WC. Current surgical management of metastatic spinal disease. Oncology. 2000;14:1013–1036.
    1. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640–650. doi: 10.1016/S0140-6736(03)14186-4.
    1. Rief H, Bischof M, Bruckner T, Welzel T, Askoxylakis V, Rieken S, Lindel K, Combs S, Debus J. The stability of osseous metastases of the spine in lung cancer–a retrospective analysis of 338 cases. Radiat Oncol. 2013;8(1):200. doi: 10.1186/1748-717X-8-200.
    1. Taneichi H, Kaneda K, Takeda N, Abumi K, Satoh S. Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine. 1997;22:239–245. doi: 10.1097/00007632-199702010-00002.
    1. Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer. 2012;3:1457–1465.
    1. Weis J, Arraras JI, Conroy T, Efficace F, Fleissner C, Görög A, Hammerlid E, Holzner B, Jones L, Lanceley A, Singer S, Wirtz M, Flechtner H, Bottomley A. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13) Psychooncology. 2013;22(5):1002–1007. doi: 10.1002/pon.3092.
    1. Book K, Marten-Mittag B, Henrich G, Dinkel A, Scheddel P, Sehlen S, Haimerl W, Schulte T, Britzelmeir I, Herschbach P. Distress screening in oncology-evaluation fo the questionaire on distress in cancer patients-short form (QSC-R10) in a German sample. Psycho-Oncology. 2011;20:287–293. doi: 10.1002/pon.1821.
    1. Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer. 2003;11:79–83.
    1. Kosteva J, Langer CJ. Incidence and distribution of skeletal metastases in NSCLC in the era of PET. Lung Cancer. 2004;46:45.
    1. Tsuya A, Kurata T, Tamura K, Fukuoka M. Skeletal metastases in non-small cell lung cancer: A retrospective study. Lung Cancer. 2007;57:229–232. doi: 10.1016/j.lungcan.2007.03.013.
    1. Lam K, Chow E, Zhang L, Wong E, Bedard G, Fairchild A, Vassiliou V, El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A. Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer. 2013;21(11):3021–3030. doi: 10.1007/s00520-013-1876-6.
    1. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. NCCN Practice Guidelines for cancer-related fatigue. Oncology. 2000;14:151–161.
    1. Mock V, Dow KH, Meares C, Grimm PM, Dienemann JA, Haisfield-Wolfe ME, Quitasol W, Mitchell S, Chakravarthy A, Gage I. Effects of exercise on fatigue, physical functioning and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum. 1997;24:991–1000.
    1. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: A systemic review. J Clin Oncol. 2007;25:1423–1436. doi: 10.1200/JCO.2006.09.5281.
    1. Klimo P Jr, Kestle JR, Schmidt MH. Clinical trials and evidence-based medicine for metastatic spine disease. Neurosurg Clin N Am. 2004;15:549–564. doi: 10.1016/j.nec.2004.04.016.
    1. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, von Gunten C, Mendel E, Vassil A, Bruner DW, Hartsell W. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Rad Oncol Biol Phys. 2011;79(4):965–976. doi: 10.1016/j.ijrobp.2010.11.026.
    1. Rief H, Muley T, Bruckner T, Welzel T, Rieken S, Bischof M, Lindel K, Combs SE, Debus J. Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients. Strahlenther Onkol. 2014;190(1):59–63. doi: 10.1007/s00066-013-0431-1.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する